BIO
Jonathan's private practice has focused on patent prosecution, opinions, and diligence matters on behalf of pharmaceutical, medical device, and financial institutions. He also worked on major patent litigations on behalf of biotechnology, pharmaceutical, interactive telephone and digital jukebox network companies. Jonathan has represented Biogen, Pfizer, AstraZeneca, Aventis, Purdue Pharma, Bayer, The Regents of the University of California, and Ecast Inc.

Jonathan practiced in-house where he managed patent portfolios and invention disclosures. He also provided freedom to operate guidance, patent landscape analyses, and cleared publication requests. Furthermore, he assisted with patent licenses, material transfer agreements, and non-disclosure agreements. Moreover, he served on in-house litigation and investigation teams and provided other general corporate legal services.

The details of Jonathan's experience are provided below:

ACADEMIC EXPERIENCE

FORDHAM UNIVERSITY SCHOOL OF LAW
Juris Doctor (2001)
COLUMBIA UNIVERSITY, COLLEGE OF PHYSICIANS AND SURGEONS
Doctor of Philosophy, Microbiology (1997)
Master of Philosophy, Microbiology (1994)

Master of Arts, Microbiology (1992)
CALIFORNIA POLYTECHNIC STATE UNIVERSITY, SAN LUIS OBISPO
Bachelor of Science, Microbiology (1991)

BAR ADMISSIONS
United States Patent and Trademark Office, 2000
New York, Second Judicial Department, 2002
California, 2003
United States District Court for the Southern District of New York, 2002
United States District Court for the Eastern District of New York, 2002
United States District Court for the Northern District of California, 2003

LEGAL EXPERIENCE

DANISCO US, GENENCOR DIVISION, Palo Alto, California,
Director, Senior Intellectual Property Counsel (2010-2011)
MEDAREX, INC., Milpitas, California,
Intellectual Property Counsel (2007-2010)
MORRISON & FOERSTER, Palo Alto, California
Patent Litigation Attorney (2003-2007)
FISH & NEAVE, New York, New York
Patent Attorney (2001-2003)
Patent Agent/Technical Advisor (1997-2001)

TECHNOLOGIES FROM PRIOR MATTERS

Industrial microbiology, industrial enzyme production and applications, first and second generation fuel ethanol
Molecular Immunology, human monoclonal antibodies, antibody engineering and production
Biotechnology, recombinant DNA technology, protein production, cell-based assay systems, knock-out and transgenic animal technology
Pharmaceuticals, including drug formulation and delivery
Stent implant technology
Interactive telephone technology
Digitally downloading jukeboxes and computer networking


PUBLICATIONS

Kaplan, Jonathan, Evaluating a Company’s Patent Position, an ExecSense eBook, ExecSense, Inc. (2012)
Kaplan’s Blawg, http://www.kaplan-iplaw.com/blog/index.html, July 12, 2012-present
Flattmann and Kaplan, Licensing Research Tool Patents, Nature Biotechnology 20:945-947 (2002);
Flattmann and Kaplan, Patenting Expressed Sequence Tags and Single Nucleotide Polymorphisms, Nature Biotechnology 19:683-684 (2001) (Part 1)
Flattmann and Kaplan, Patenting Expressed Sequence Tags and Single Nucleotide Polymorphisms, Nature Biotechnology 19:777-779 (2001) (Part 2)
Kaplan & Calame, The ZiN/POZ Domain of ZF5 is Required for Both Transcriptional Activation and Repression, Nucleic Acids Research 25:1108-1116 (1997)
Numoto et al., Transcriptional Repressor ZF5 Identifies a New Conserved Domain in Zinc Finger Proteins, Nucleic Acids Research 21:3767-3775 (1993)

Kaplan IP Law Brochure